Skip to main content
Equibles
STTK logo

STTK · Shattuck Labs, Inc. · Metrics

Track STTK — free

Use STTK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STTK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.62 +0.13 (+2.90%) At close · Nov 6 Q3 2023 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$470.51M
Shares
101.84M
Volume · Nov 6 1.15M Avg daily vol (3M) 1.14M

STTK metrics

59 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.62
Market cap
$470.51M

Price action

23 metrics
Price change (1W)
-21.5%
Price change (30D)
-20.6%
Price change (3M)
-37.3%
Price change (6M)
-28.3%
Price change (YTD)
+23.0%
Price change (1Y)
+120.1%
Trailing year
Price change (5Y)
-75.7%
52-week high
$8.06
52-week low
$1.84
Change from 52-week high
-44.3%
Change from 52-week low
+144.0%
Annualized volatility
78.1%
Annualized volatility (3M)
62.5%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.2
RSI (14D)
29.5
Price vs SMA 50
-26.0%
Price vs SMA 200
-25.8%
Avg volume (3M)
1.13M
Relative volume
1.3
Average dollar volume
$7.17M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
101.84M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.4
reciprocal yield 42.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-14.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2023-11-09

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$72.12M
Net income (TTM)
−$67.72M
Trailing 12 months
Diluted EPS (TTM)
$-0.44
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.30

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+153.8%
Year over year · more shares
Revenue CAGR (3Y)
+15.3%
Revenue CAGR (5Y)
-36.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-35.0%
Return on assets
-32.6%
Debt / equity
—
Current ratio
15.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
15.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$61.76M
Latest balance sheet
Cash & equivalents
$61.76M
Total assets
$207.97M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$49.57M
Capital expenditures (TTM)
$191,000
R&D (TTM)
$53.27M
SG&A (TTM)
—
Stock compensation (TTM)
$10.05M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
103
13F filer change QoQ
+19
Institutional ownership
83.0%
Conviction holders (share of 13F filers)
4.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+40.2%
Holder tenure
8.5
Price vs estimated holder cost
-2.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
6.4%

Short interest

3 metrics
Short interest
10.3%
Latest settlement · 7.2 days to cover
Days to cover
7.2d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1680367 CUSIP 82024L103 13F (30d) 41 filings 29 filers Visit website Investor relations